颈动脉内中膜厚度与动脉粥样硬化斑块与肾功能下降相关:一项为期14年的纵向人群研究
在德国波美拉尼亚健康研究(SHIP)人群中,2904名受试者随访14年,采用标准化B型超声测量颈动脉内中膜厚度(cIMT)和斑块,发现基线高cIMT和存在斑块与eGFR下降及CKD发生风险增加相关,但与白蛋白尿发生风险无关;FAS方程最适应本研究人群。
要点
- 基线高cIMT和颈动脉斑块与随访期间eGFR下降及CKD发生风险增加相关。
- 颈动脉粥样硬化参数与白蛋白尿发生风险无关联。
- FAS方程最适应本研究人群的eGFR计算。
核心结论
- 在人群样本中,cIMT和颈动脉斑块与肾功能下降及CKD相关;FAS方程最适应本研究人群。
研究设计与样本
- 基于德国波美拉尼亚健康研究(SHIP)人群的纵向研究,纳入2904名受试者,随访14年。
- 采用标准化B型超声协议测量颈动脉内中膜厚度(cIMT)和颈动脉斑块。
- CKD定义为估算肾小球滤过率(eGFR)<60 mL/min/1.73 m2,白蛋白尿定义为尿白蛋白-肌酐比值(ACR)≥30 mg/g。
- eGFR分别采用FAS方程和CKD-EPI方程计算,应用混合模型纵向分析颈动脉参数与肾功能变化的关系并校正混杂因素。
主要发现
- 基线高cIMT和存在斑块者随访期间eGFR下降更明显(cIMT:FAS-eGFR P<.001,CKD-EPI-eGFR P<.001;斑块:FAS-eGFR P<.001,CKD-EPI-eGFR n.s.)。
- 基线高cIMT和存在斑块者随访期间CKD发生风险增加(cIMT:FAS-eGFR P=.001,CKD-EPI-eGFR P=.04;斑块:FAS-eGFR P=.008,CKD-EPI-eGFR P=.001)。
- 颈动脉粥样硬化参数与白蛋白尿发生风险之间无关联。
关键数值与推荐
- CKD定义为eGFR<60 mL/min/1.73 m2,白蛋白尿定义为ACR≥30 mg/g。
- 研究样本基线年龄范围25-86岁,中位年龄54岁。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic kidney disease (CKD) leads to increased morbidity and mortality. The underlying causes of CKD are often similar to those of atherosclerosis. We investigated whether carotid atherosclerotic parameters are associated with renal function decline. METHODS: Within the population-based Study of Health in Pomerania (SHIP), Germany, 2904 subjects were observed over 14 years. The carotid intima-media thickness (cIMT) as well as carotid plaques were measured by standardized B-mode ultrasound protocol. CKD is defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 and albuminuria as urinary albumin-creatinine ratio (ACR) ≥30 mg/g. eGFR was calculated by the full age spectrum (FAS) equation and the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. Mixed models were applied to associate carotid parameters with change in renal function longitudinally and adjusted for confounding. RESULTS: The age range of the study sample was 25-86 years with a median of 54 years at baseline. In longitudinal analyses, subjects with high cIMT and the presence of plaques at baseline showed a greater decrease in eGFR (cIMT: FAS-eGFR: P < .001, CKD-EPI-eGFR: P < .001; plaques: FAS-eGFR: P < .001, CKD-EPI-eGFR: n.s.) as well as an increased risk of developing CKD during the follow-up (cIMT: FAS-eGFR: P = .001, CKD-EPI-eGFR: P = .04; plaques: FAS-eGFR: P = .008, CKD-EPI-eGFR: P = .001). There was no association between atherosclerotic parameters and the risk of developing albuminuria. CONCLUSIONS: cIMT and carotid plaques are associated with renal function decline as well as CKD in a population-based sample. Furthermore, the FAS equation adapts best to this study population.
引用
- Goepfert M, Ittermann T, Dörr M, et al. Carotid intima-media thickness and atherosclerotic plaques are associated with renal function decline: a 14-year longitudinal population-based study. Nephrol Dial Transplant. 2023. PMID: 37222460. doi:10.1093/ndt/gfad104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。